Clinical Trials Browser

denileukin diftitox × Genitourinary × Clear all

NCT00082914 2013-06-20

Denileukin Diftitox in Treating Patients With Metastatic Melanoma or Metastatic Kidney Cancer

Phase 2 Completed

DermatologicGenitourinary

Carcinoma, Renal Cell, Kidney Neoplasms, Melanoma

NCT00278369 2013-05-22

Pilot Study of Denileukin Diftitox Plus High-Dose IL-2 for Patients With Metastatic Renal Cancer

Phase EARLY_PHASE1 Completed

Carcinoma, Renal Cell, Kidney Neoplasms